Drug class in one race

Thyroid hormone receptor-beta drugs for MASH / NASH

2 tracked Thyroid hormone receptor-beta drugs in the MASH / NASH race. The class explanation lives on the Thyroid hormone receptor-beta page; the full indication pipeline across every mechanism is on the MASH / NASH page.

1 approved / phase 41 Phase 2

Head-to-head evidence: Resmetirom vs VK2809

The roster

← all Thyroid hormone receptor-beta drugs